DNA-PKcs activity also correlated with resistance to cisplatin in glioma [197] and chemoresistance in B-cell chronic lymphocytic leukemia (CLL) [198]. The gene discussed is PRKDC; the disease is B-cell chronic lymphocytic leukemia.